Researchers suggest targeting ECM-mediated regulation of autophagy levels could be used to sensitize pancreatic cancer to FDA-approved therapies.

A feature of pancreatic cancer cells' surroundings determines whether they grow fast or become resistant to chemotherapy, a new study shows.

Sanara MedTech Inc. ('Sanara,” the 'Company,” 'we,” 'our” or 'us”) (Nasdaq: SMTI), a medical technology company focused on ...

Two experts share the Aussie names with big catalysts on the horizon.

Researchers used advanced imaging to uncover early molecular changes in bone that may enable earlier diagnosis of ...

Discover the groundbreaking research on organoid models for spinal cord injury, promising new therapies for paralysis recovery.

A new human spinal cord organoid model replicates key injury responses, such as inflammation, cell loss, and scar formation.

Merck , known as MSD outside of the United States and Canada, announced today that Health Canada has approved KEYTRUDA SCtm (pembrolizumab injection), a new subcutaneous formulation of pembrolizumab, ...

Barça Innovation Hub and IDIBAPS have published a groundbreaking article that analyses, for the first time, the epigenome of footballers from both the men’s and women’s teams, exploring whether ...

In this interview, Dr. Marsh Durban explores how innovations such as controlled seeding and size‑selection are enabling researchers to generate uniform, assay‑ready organoids at scale.

Galderma (SIX: GALD), the pure-play dermatology category leader, today unveiled We Are All Sculptra, a unique program designed to capture the clinical impact of Sculptra ® across nine diverse patients ...